OPS
RNAM

Orion Portfolio Solutions’s Avidity Biosciences RNAM Stock Holding History

Orion Portfolio Solutions’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$676K Buy
22,886
+12,197
+114% +$380K 0.01% 1265
2024
Q4 		$311K Sell
10,689
-949
-8% -$39.7K ﹤0.01% 1545
2024
Q3 		$535K Buy
+11,638
New +$505K 0.01% 1311

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orion Portfolio Solutions's RNAM Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Avidity Biosciences (RNAM) stake by 114% in Q1 2025, buying an estimated $380K and bringing the position to 22,886 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #1265.

Orion Portfolio Solutions first reported a position in RNAM in Q3 2024 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold RNAM as of Q1 2025.

  • Orion Portfolio Solutions held 22,886 shares of Avidity Biosciences worth $676K as of Q1 2025.
  • Orion Portfolio Solutions bought 12,197 Avidity Biosciences shares in Q1 2025, an estimated $380K.
  • Avidity Biosciences made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1265 holding.
  • Orion Portfolio Solutions first reported a position in Avidity Biosciences in Q3 2024 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.